{
    "Trade/Device Name(s)": [
        "MicroScan MICroSTREP plus Panel Azithromycin (0.12 - 4 mcg/ml)",
        "Microdilution Minimum Inhibitory Concentration (MIC) Panels"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K062585",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021169"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LRG",
        "LTT"
    ],
    "Summary Letter Date": "August 18, 2006",
    "Summary Letter Received Date": "September 1, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Azithromycin"
    ],
    "Specimen Type(s)": [
        "Bacterial colonies grown on solid media"
    ],
    "Specimen Container(s)": [
        "Panel",
        "Solid media plate"
    ],
    "Instrument(s)/Platform(s)": [
        "MicroScan WalkAway instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution antimicrobial susceptibility test"
    ],
    "Methodologies": [
        "Minimum Inhibitory Concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Panel",
        "Reagent",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan MICroSTREP plus Panel for Azithromycin susceptibility testing in aerobic streptococci using MIC determination and instrument read capability",
    "Indications for Use Summary": "Used to determine quantitative and/or qualitative antimicrobial susceptibility of aerobic streptococci, including Streptococcus pneumoniae, to Azithromycin using manual or instrument read methods",
    "fda_folder": "Microbiology"
}